EV/EBITDA
87.96
-3.49-3.82%
22 min ago
Summary
- As of February 7, 2025, GYRE EV/EBITDA is 87.96, with a fall of -3.49 (-3.82%) during the most recent trading day.
- Over the past year, GYRE EV/EBITDA has increased by +39.36 (+80.99%).
- GYRE EV/EBITDA is now -27.03% below its all-time high of 120.54.
Performance
GYRE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
GYRE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.8% | -3.8% | -3.8% |
| 1 m1 month | +23.1% | +23.1% | +22.7% |
| 3 m3 months | -18.7% | -18.8% | -18.6% |
| 6 m6 months | +109.8% | +23.3% | +22.6% |
| ytdytd | +1.3% | +1.3% | +1.3% |
| 1 y1 year | +81.0% | +5.1% | +2.5% |
| 5 y5 years | - | - | -90.4% |
GYRE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.8% | 68.76 | +27.9% | |
| 3 m | 3-month | 120.54 | -27.0% | 68.76 | +27.9% |
| 6 m | 6-month | 120.54 | -27.0% | 41.07 | +114.2% |
| 1 y | 1-year | 120.54 | -27.0% | 35.24 | +149.6% |
| 3 y | 3-year | 120.54 | -27.0% | 35.24 | +149.6% |
| 5 y | 5-year | 120.54 | -27.0% | 35.24 | +149.6% |
| alltime | all time | 120.54 | -27.0% | 35.24 | +149.6% |
Gyre Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 87.96(+1.3%) |
| Date | Value |
|---|---|
| 2024 | 86.80(-8.8%) |
| 2023 | 95.18 |
FAQ
- What is Gyre Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Gyre Therapeutics?
- What is GYRE EV/EBITDA year-to-date change?
- What is Gyre Therapeutics EV/EBITDA year-on-year change?
What is Gyre Therapeutics EV/EBITDA?
The current EV/EBITDA of GYRE is 87.96
What is the all time high EV/EBITDA for Gyre Therapeutics?
Gyre Therapeutics all-time high EV/EBITDA is 120.54
What is GYRE EV/EBITDA year-to-date change?
Gyre Therapeutics EV/EBITDA has changed by +1.16 (+1.34%) since the beginning of the year
What is Gyre Therapeutics EV/EBITDA year-on-year change?
Over the past year, GYRE EV/EBITDA has changed by +39.36 (+80.99%)